Compare · HIMS vs NAKA
HIMS vs NAKA
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Nakamoto Inc. (NAKA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and NAKA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.29B, about 77.2x NAKA ($81.4M).
- Over the past year, HIMS is down 52.2% and NAKA is down 99.1% - HIMS leads by 46.9 points.
- HIMS has been more active in the news (20 items in the past 4 weeks vs 8 for NAKA).
- HIMS has more recent analyst coverage (25 ratings vs 3 for NAKA).
- Company
- Hims & Hers Health Inc.
- Nakamoto Inc.
- Price
- -
- -
- Market cap
- $6.29B
- $81.4M
- 1M return
- +5.88%
- -35.32%
- 1Y return
- -52.20%
- -99.13%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2024
- News (4w)
- 20
- 8
- Recent ratings
- 25
- 3
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest HIMS
- Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
- Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
- Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health Platform
- Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
- Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
- Director Wells David B bought $1,172,974 worth of shares (48,400 units at $24.23), increasing direct ownership by 27% to 224,417 units (SEC Form 4)
- SEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison
Latest NAKA
- Amendment: SEC Form SCHEDULE 13D/A filed by Nakamoto Inc.
- Nakamoto Chairman and CEO David Bailey Purchases Additional Shares of Common Stock
- Chief Executive Officer Bailey David F bought $309,516 worth of shares (55,115 units at $5.62), increasing direct ownership by 2% to 3,175,476 units (SEC Form 4)
- Chief Executive Officer Bailey David F bought $683,112 worth of shares (136,333 units at $5.01), increasing direct ownership by 5% to 3,120,361 units (SEC Form 4)
- Nakamoto Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Nakamoto Announces Expansion of Board of Directors
- Bitcoin for Corporations to Host the First Dedicated Institutional Bitcoin Symposium in New York City
- Following Stockholder Approval, Nakamoto Announces 1-for-40 Reverse Stock Split to be Effective on May 22, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Nakamoto Inc.
- Nakamoto Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits